IBRX Immunitybio, Inc.

Fundamentals / CIK 0001326110 / USD

Immunitybio, Inc. reported $182.6M in revenue and a net loss of $1.11B for the trailing twelve months ended September 30, 2026 (up 52.3% year over year), with a 98.8% gross margin and a -150.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IBRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$173.2M$86.62M$0-$554.9MFY 2016 Revenue: $44KFY 2016 Net Income: -$120.8M2016FY 2017 Revenue: $45KFY 2017 Net Income: -$96.42M2017FY 2018 Revenue: $47KFY 2018 Net Income: -$96.23M2018FY 2019 Revenue: $2.20MFY 2019 Net Income: -$157.8M2019FY 2020 Revenue: $605KFY 2020 Net Income: -$221.9M2020FY 2021 Revenue: $934KFY 2021 Net Income: -$346.8M2021FY 2022 Revenue: $240KFY 2022 Net Income: -$416.6M2022FY 2023 Revenue: $622KFY 2023 Net Income: -$583.2M2023FY 2024 Revenue: $14.74MFY 2024 Net Income: -$413.6M2024FY 2025 Revenue: $113.3MFY 2025 Net Income: -$351.4M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $113.3M $14.74M $622K $240K $934K $605K $2.20M $47K $45K $44K
Cost of Revenue $753K $0 $0 $0 -- -- -- -- -- --
Gross Profit $112.5M $14.74M $622K $240K -- -- -- -- -- --
Research & Development -- $190.1M $232.4M $248.1M $196.0M $139.5M $112.0M $55.72M $42.04M $29.15M
Selling, General & Admin -- $168.8M $129.6M $102.7M $135.3M $71.32M $46.46M $42.72M $57.12M $95.39M
Total Operating Expenses -- $358.9M $362.9M $351.5M $331.2M $221.5M $158.5M $98.44M $99.17M $124.5M
Operating Income -$256.0M -$344.2M -$362.2M -$351.3M -$330.3M -$220.9M -$156.3M -$98.39M -$99.12M -$124.5M
EBITDA -$240.5M -$326.6M -$343.7M -$333.0M -$316.0M -$208.1M -$142.2M -$88.83M -$93.55M -$120.9M
Interest Income -- -- -- -- -- $1.23M $1.64M $2.32M $4.22M $5.17M
Interest Expense $60.89M $114.6M $128.8M $63.52M $14.85M $9.07M $5.92M -- $618K $66K
Income Before Tax -$351.6M -$413.6M -$583.9M -$417.3M -$349.8M -$226.0M -$160.3M -$96.73M -$96.92M -$121.4M
Income Tax Expense -$135K $0 -$40K $34K $9.0K -$1.85M -$105K -$503K -$493K -$572K
Net Income -$351.4M -$413.6M -$583.2M -$416.6M -$346.8M -$221.9M -$157.8M -$96.23M -$96.42M -$120.8M
Basic EPS -$0.38 -$0.59 -$1.15 -$1.04 -$0.89 -$0.59 -$0.43 -$1.22 -$1.20 -$1.47
Diluted EPS -$0.38 -$0.62 -$1.15 -$1.04 -$0.89 -$0.59 -$0.43 -$1.22 -$1.20 -$1.47
Basic Shares Outstanding 919.9M 697.3M 508.6M 399.9M 389.2M 377.1M 366.3M 79.1M 80.6M 82.0M
Diluted Shares Outstanding 919.9M 700.4M 508.6M 399.9M 389.2M 377.1M 366.3M 79.1M 80.6M 82.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $48.84M $51.24M $44.21M $38.28M $32.06M $26.43M $16.52M $7.55M
Cost of Revenue $1.29M $298K $238K $382K $177K $136K $58K $0
Gross Profit $47.55M $50.94M $43.97M $37.90M $31.88M $26.29M $16.46M $7.55M
Research & Development -- -- -- -- -- -- -- $35.22M
Selling, General & Admin -- -- -- -- -- -- -- $41.73M
Total Operating Expenses -- -- -- -- -- -- -- $76.95M
Operating Income -$77.99M -$61.70M -$69.79M -$64.68M -$55.63M -$71.28M -$64.43M -$69.40M
EBITDA -$74.10M -$57.29M -$65.41M -$60.82M -$51.68M -$67.41M -$60.60M -$65.26M
Interest Expense -- -- -- $14.84M $15.26M $15.47M $15.31M $26.02M
Income Before Tax -$184.6M -$230.4M -$632.8M -$62.09M -$67.31M -$92.31M -$129.9M -$59.18M
Income Tax Expense $0 $0 $9.0K -$135K -$35K $269K -$234K $0
Net Income -$184.6M -$230.4M -$632.8M -$61.94M -$67.25M -$92.56M -$129.6M -$59.16M
Basic EPS -$0.17 -$0.22 -$0.62 -- -$0.07 -$0.10 -$0.15 --
Diluted EPS -$0.18 -$0.22 -$0.62 -- -$0.07 -$0.10 -$0.15 --
Basic Shares Outstanding 1.06B 1.05B 1.03B -- 946.6M 888.2M 853.2M --
Diluted Shares Outstanding 1.06B 1.05B 1.03B -- 946.6M 888.2M 853.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $88.33M $143.4M $265.5M $104.6M $181.1M $34.91M $75.80M $16.82M $23.87M $8.08M
Short-Term Investments $154.5M $6.38M $1.01M $2.54M $136.0M $61.15M $36.14M $57.33M $104.3M $190.8M
Cash & Short-Term Investments $242.8M $149.8M $266.5M $107.2M $317.1M $96.06M $111.9M $74.15M $128.2M $198.9M
Accounts Receivable, Net $42.57M $2.36M $0 -- -- -- -- -- -- --
Inventory $910K $8.27M $0 -- -- -- -- -- -- --
Other Current Assets $2.13M $1.30M $1.54M $1.98M $2.96M $110K $24K $42K $275K $275K
Total Current Assets $314.9M $184.6M $294.1M $140.6M $334.3M $111.7M $55.76M $88.77M $132.5M $205.1M
Property, Plant & Equipment, Net $114.3M $137.1M $146.1M $143.7M $82.86M $72.54M $60.50M $76.89M $76.73M $18.91M
Goodwill $910K $910K -- -- -- -- -- -- -- --
Intangible Assets $12.99M $14.53M $17.09M $20.00M $1.42M $1.46M $0 $565K $2.83M $5.09M
Long-Term Investments -- $0 $891K $840K $822K $950K $1.50M $5.70M $29.60M $87.57M
Other Non-Current Assets -- $4.83M $2.88M $4.86M $6.78M $2.60M $4.39M $1.53M $330K $788K
Total Non-Current Assets $187.0M $198.3M $210.4M $221.8M $134.6M $109.7M $87.37M $93.18M $118.0M $112.4M
Total Assets $501.9M $382.9M $504.5M $362.4M $468.9M $221.4M $143.1M $181.9M $250.4M $317.5M
Accounts Payable -- -- -- $21.02M $11.42M $11.51M $1.75M $2.79M $5.87M $4.04M
Short-Term Debt $1.75M $1.25M -- -- -- -- -- -- -- --
Other Current Liabilities -- -- -- -- -- $1.44M $775K $1.67M $1.37M $891K
Total Current Liabilities $61.75M $54.94M $58.28M $500.9M $369.0M $68.13M $11.56M $27.26M $20.87M $12.55M
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- -- $166K $187K
Other Non-Current Liabilities $424K $319K $1.11M $457K $411K $1.03M -- $0 $255K $240K
Total Non-Current Liabilities $939.7M $816.1M $1.03B $311.3M $343.8M $271.7M $10.88M $8.68M $10.73M $11.53M
Total Liabilities $1.00B $871.1M $1.09B $812.2M $712.8M $339.9M $22.44M $35.94M $31.60M $24.08M
Total Debt (incl. Leases) $43.01M $43.54M $45.25M $50.74M $40.08M $15.31M $14.09M -- -- --
Common Stock $101K $85K $67K $42K $40K $38K $10K $8.0K $8.0K $8.0K
Retained Earnings -$3.73B -$3.38B -$2.96B -$2.38B -$1.96B -$1.62B -$662.2M -$595.0M -$498.7M -$387.1M
Accumulated Other Comp. Income $28.96M $1.20M $10K $183K $4.0K $122K -$105K -$267K -$381K -$284K
Total Stockholders' Equity -$500.5M -$489.1M -$587.0M -$447.3M -$242.2M -$119.8M $120.7M $146.0M $218.8M $293.4M
Total Equity -$499.6M -$488.1M -$585.9M -$449.8M -$243.9M -$118.5M $16.33M $81.94M $218.8M $293.4M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $45.08M $75.67M $205.2M $88.33M $60.24M $137.7M $60.66M $143.4M
Short-Term Investments $289.2M $281.7M $175.7M $154.5M $197.6M $16.00M $931K $6.38M
Cash & Short-Term Investments $334.3M $357.4M $380.9M $242.8M $257.8M $153.7M $61.59M $149.8M
Accounts Receivable, Net $53.60M $53.47M $43.27M $42.57M $32.02M $22.13M $17.03M $2.36M
Inventory $6.0K $1.94M $547K $910K $6.70M $6.64M $8.44M $8.27M
Other Current Assets -- -- $3.02M $2.13M $2.51M $1.64M $2.35M $1.30M
Total Current Assets $418.8M $439.0M $453.0M $314.9M $329.5M $208.1M $109.2M $184.6M
Property, Plant & Equipment, Net $115.1M $114.2M $112.8M $114.3M $129.6M $133.0M $135.3M $137.1M
Goodwill -- -- $910K $910K $910K $910K $910K $910K
Intangible Assets -- -- $11.91M $12.99M $13.53M $13.51M $14.02M $14.53M
Long-Term Investments -- -- -- -- -- -- -- $0
Other Non-Current Assets -- -- -- -- -- -- -- $4.83M
Total Non-Current Assets $190.6M $189.5M $193.7M $187.0M $189.5M $193.9M $194.6M $198.3M
Total Assets $609.4M $628.5M $646.6M $501.9M $519.0M $402.1M $303.8M $382.9M
Short-Term Debt -- -- $884K $1.75M $2.60M -- -- $1.25M
Total Current Liabilities $98.09M $76.73M $67.95M $61.75M $57.13M $50.64M $49.20M $54.94M
Other Non-Current Liabilities $1.01M $510K $472K $424K $702K $710K $370K $319K
Total Non-Current Liabilities $1.66B $1.60B $1.45B $939.7M $985.3M $921.3M $845.0M $816.1M
Total Liabilities $1.75B $1.67B $1.52B $1.00B $1.04B $971.9M $894.2M $871.1M
Total Debt (incl. Leases) $34.82M $38.97M $41.92M $43.01M $44.34M $43.53M $40.56M $43.54M
Common Stock $106K $105K $104K $101K $98K $91K $85K $85K
Retained Earnings -$4.77B -$4.59B -$4.36B -$3.73B -$3.66B -$3.60B -$3.50B -$3.38B
Accumulated Other Comp. Income $26.88M $27.28M $27.45M $28.96M $5.00M $12.57M $19.96M $1.20M
Total Stockholders' Equity -$1.15B -$1.05B -$870.0M -$500.5M -$524.3M -$570.7M -$591.4M -$489.1M
Total Equity -$1.15B -$1.05B -$869.1M -$499.6M -$523.4M -$569.8M -$590.5M -$488.1M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$351.5M -$413.6M -$583.9M -$417.3M -$349.8M -$224.2M -$160.2M -$96.23M -$96.42M -$120.8M
Depreciation & Amortization $15.53M $17.55M $18.51M $18.26M $14.24M $12.74M $14.04M $9.55M $5.57M $3.61M
Stock-Based Compensation $36.81M $34.43M $49.16M $40.18M $57.18M $2.19M $3.42M $23.38M $37.00M $73.85M
Change in Receivables -$40.21M -$2.36M $0 $0 -- -- -- -- -- --
Change in Inventory -$6.33M -$8.27M $0 $0 -- -- -- -- -- --
Change in Payables -$190K -$3.17M -$6.48M $8.00M -$3.72M $2.57M $1.19M -$1.10M $150K $888K
Operating Cash Flow -$304.9M -$391.2M -$366.8M -$337.5M -$274.4M -$171.7M -$152.1M -$63.38M -$48.78M -$38.59M
Capital Expenditure -$3.85M -$6.89M -$30.58M -$78.16M -$33.56M -$1.67M -$4.29M -$13.10M -$34.81M -$6.56M
Free Cash Flow -$308.8M -$398.1M -$397.3M -$415.7M -$308.0M -$173.4M -$156.4M -$76.48M -$83.59M -$45.15M
Acquisitions, Net -- -- -- -- -- -- -- -- $0 $0
Purchases of Investments -$241.4M -$140.2M -$10.36M -$34.31M -$141.8M -$91.57M -$86.62M $0 -$8.50M $0
Sales & Maturities of Investments -- -- -- -- -- $73.62M $112.3M $165.3M -- --
Investing Cash Flow -$149.8M -$12.25M -$30.47M $27.30M -$84.89M -$19.81M $18.55M $57.10M $99.55M -$113.7M
Common Stock Issued -- -- -- $60.43M $164.5M $86.30M $30.00M $0 $0 $0
Share Repurchases -- -- -- -- $0 $0 -$2.50M -$228K -$15.23M -$15.85M
Financing Cash Flow $400.2M $281.6M $558.3M $233.6M $505.4M $150.7M $114.3M -$771K -$34.98M -$15.56M
Net Change in Cash -$54.48M -$121.9M $160.8M -$76.31M $146.2M -$40.89M -$19.30M -$7.05M $15.79M -$167.8M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$184.6M -$230.4M -$632.8M -$61.96M -$67.27M -$92.57M -$129.7M -$59.18M
Depreciation & Amortization $3.89M $4.41M $4.38M $3.87M $3.95M $3.88M $3.83M $4.14M
Stock-Based Compensation $8.72M $8.52M $8.17M $8.75M $8.88M $9.65M $9.54M $9.04M
Change in Receivables -$126K -$10.20M -$700K -$10.55M -$9.89M -$5.10M -$14.67M $1.81M
Change in Inventory -$2.69M $1.01M -$4.99M -$7.89M -$63K $1.80M -$172K -$6.31M
Change in Payables $1.81M -$247K $3.90M $979K -$1.39M -$6.22M $6.44M -$3.21M
Operating Cash Flow -$75.33M -$66.49M -$75.36M -$70.38M -$68.91M -$79.75M -$85.91M -$85.14M
Capital Expenditure -$2.93M -$3.52M -$1.78M -$903K -$741K -$1.08M -$1.12M -$2.11M
Free Cash Flow -$78.26M -$70.01M -$77.14M -$71.28M -$69.65M -$80.83M -$87.03M -$87.25M
Purchases of Investments -$109.5M -$164.2M -$139.1M -$45.63M -$180.6M -$15.06M -$100K -$6.09M
Investing Cash Flow -$8.04M -$107.5M -$31.65M $43.57M -$181.4M -$16.14M $4.13M $9.83M
Financing Cash Flow $53.03M $44.44M $223.9M $54.89M $173.5M $172.8M -$982K $106.9M
Net Change in Cash -$30.59M -$129.5M $117.0M $28.09M -$76.81M $77.00M -$82.77M $31.61M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 99.3% 100.0% 100.0% 100.0% -- -- -- -- -- --
Operating Margin -226.0% -2334.2% -58239.5% -146374.2% -35361.9% -36509.1% -7095.9% -209338.3% -220266.7% -282954.5%
Net Profit Margin -310.2% -2804.8% -93761.4% -173569.6% -37129.6% -36669.6% -7165.2% -204736.2% -214273.3% -274565.9%
Return on Equity (ROE) -- -- -- -- -- -- -130.7% -65.9% -44.1% -41.2%
Return on Assets (ROA) -70.0% -108.0% -115.6% -115.0% -74.0% -100.2% -110.2% -52.9% -38.5% -38.1%
Current Ratio 5.10x 3.36x 5.05x 0.28x 0.91x 1.64x 4.82x 3.26x 6.35x 16.34x
Quick Ratio 5.08x 3.21x 5.05x 0.21x 0.86x 1.41x 9.68x 2.72x 6.14x 15.85x
Debt to Equity -- -- -- -- -- -- 0.12x -- -- --
Revenue Growth (YoY) +668.3% +2270.6% +159.2% -74.3% +54.4% -72.5% +4585.1% +4.4% +2.3% -81.4%
Gross Profit Growth (YoY) +663.2% +2270.6% +159.2% -- -- -- -- -- -- --
5Y Revenue / Share Growth +7575.8% +251.8% +105.9% +7.5% +347.1% -51.4% -92.3% -99.9% -- --
10Y Revenue / Share Growth +3632.3% -72.8% -99.8% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 98.8% 99.3% 99.3% 99.3% 99.6% 99.7% 99.8% 100.0%
Operating Margin -150.2% -151.9% -185.4% -226.0% -315.8% -504.2% -1003.8% -2334.2%
Net Profit Margin -607.8% -598.6% -606.2% -310.2% -422.3% -648.6% -1310.3% -2804.8%
Return on Assets (ROA) -182.1% -157.9% -132.2% -70.0% -67.2% -91.3% -134.7% -108.0%
Current Ratio 4.27x 5.72x 6.67x 5.10x 5.77x 4.11x 2.22x 3.36x
Quick Ratio 4.27x 5.70x 6.66x 5.08x 5.65x 3.98x 2.05x 3.21x
Revenue Growth (YoY) +52.3% +93.9% +167.6% +407.0% +425.1% +2423.9% +41192.5% +5333.1%
Gross Profit Growth (YoY) +49.1% +93.8% +167.1% +401.9% +422.2% +2410.9% +41047.5% --
Source: SEC EDGAR CompanyFacts (CIK 0001326110) · from December 31, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:12 UTC · Open in terminal